These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 15881989)
1. PRRSV planned exposure and the law. O'Rourke K J Am Vet Med Assoc; 2005 May; 226(9):1461-2. PubMed ID: 15881989 [No Abstract] [Full Text] [Related]
2. Evaluation of protective immunity in gilts inoculated with the NADC-8 isolate of porcine reproductive and respiratory syndrome virus (PRRSV) and challenge-exposed with an antigenically distinct PRRSV isolate. Lager KM; Mengeling WL; Brockmeier SL Am J Vet Res; 1999 Aug; 60(8):1022-7. PubMed ID: 10451216 [TBL] [Abstract][Full Text] [Related]
3. Adjuvants for porcine reproductive and respiratory syndrome virus vaccines. Charerntantanakul W Vet Immunol Immunopathol; 2009 May; 129(1-2):1-13. PubMed ID: 19157569 [TBL] [Abstract][Full Text] [Related]
4. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus. Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity. Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420 [TBL] [Abstract][Full Text] [Related]
6. Role of neutralizing antibodies in PRRSV protective immunity. Lopez OJ; Osorio FA Vet Immunol Immunopathol; 2004 Dec; 102(3):155-63. PubMed ID: 15507302 [TBL] [Abstract][Full Text] [Related]
7. Immunologic responses and reproductive outcomes following exposure to wild-type or attenuated porcine reproductive and respiratory syndrome virus in swine under field conditions. Lowe JF; Zuckermann FA; Firkins LD; Schnitzlein WM; Goldberg TL J Am Vet Med Assoc; 2006 Apr; 228(7):1082-8. PubMed ID: 16579789 [TBL] [Abstract][Full Text] [Related]
8. DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity. Jiang Y; Xiao S; Fang L; Yu X; Song Y; Niu C; Chen H Vaccine; 2006 Apr; 24(15):2869-79. PubMed ID: 16446016 [TBL] [Abstract][Full Text] [Related]
9. Negative impact of porcine reproductive and respiratory syndrome virus infection on the efficacy of classical swine fever vaccine. Suradhat S; Kesdangsakonwut S; Sada W; Buranapraditkun S; Wongsawang S; Thanawongnuwech R Vaccine; 2006 Mar; 24(14):2634-42. PubMed ID: 16406169 [TBL] [Abstract][Full Text] [Related]
10. Effect of vaccination with a modified-live porcine reproductive and respiratory syndrome virus vaccine on dynamics of homologous viral infection in pigs. Cano JP; Dee SA; Murtaugh MP; Trincado CA; Pijoan CB Am J Vet Res; 2007 May; 68(5):565-71. PubMed ID: 17472459 [TBL] [Abstract][Full Text] [Related]
12. Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18. Shen G; Jin N; Ma M; Jin K; Zheng M; Zhuang T; Lu H; Zhu G; Jin H; Jin M; Huo X; Qin X; Yin R; Li C; Li H; Li Y; Han Z; Chen Y; Jin M Vaccine; 2007 May; 25(21):4193-202. PubMed ID: 17418456 [TBL] [Abstract][Full Text] [Related]
13. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets. Qiu HJ; Tian ZJ; Tong GZ; Zhou YJ; Ni JQ; Luo YZ; Cai XH Vet Immunol Immunopathol; 2005 Jul; 106(3-4):309-19. PubMed ID: 15963827 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of porcine reproductive and respiratory syndrome virus vaccine and porcine interleukin-12. Wee GJ; Cao MJ; Liu W; Kwang J Vet Ther; 2001; 2(2):112-9. PubMed ID: 19753703 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. Zuckermann FA; Garcia EA; Luque ID; Christopher-Hennings J; Doster A; Brito M; Osorio F Vet Microbiol; 2007 Jul; 123(1-3):69-85. PubMed ID: 17376612 [TBL] [Abstract][Full Text] [Related]
16. Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice. Jiang W; Jiang P; Li Y; Tang J; Wang X; Ma S Vet Immunol Immunopathol; 2006 Sep; 113(1-2):169-80. PubMed ID: 16777236 [TBL] [Abstract][Full Text] [Related]
17. PRRS: is elimination attainable? Kahler SC J Am Vet Med Assoc; 2004 May; 224(9):1408-9. PubMed ID: 15124875 [No Abstract] [Full Text] [Related]
18. A recombinant plasmid co-expressing swine ubiquitin and the GP5 encoding-gene of porcine reproductive and respiratory syndrome virus induces protective immunity in piglets. Hou YH; Chen J; Tong GZ; Tian ZJ; Zhou YJ; Li GX; Li X; Peng JM; An TQ; Yang HC Vaccine; 2008 Mar; 26(11):1438-49. PubMed ID: 18262692 [TBL] [Abstract][Full Text] [Related]
19. Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent. Lopez OJ; Oliveira MF; Garcia EA; Kwon BJ; Doster A; Osorio FA Clin Vaccine Immunol; 2007 Mar; 14(3):269-75. PubMed ID: 17215336 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus. Jiang Y; Fang L; Xiao S; Zhang H; Pan Y; Luo R; Li B; Chen H Vaccine; 2007 Jan; 25(3):547-60. PubMed ID: 16920232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]